Sign in

CIK 0001730430 · Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981795578
Phone
7814319100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 8-K Event Results of operations
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  5. 4 Insider Changes in Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. 5 Insider Annual Insider Trading Report
  10. 3 Insider Initial Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  14. 8-K Event Executive or director change
  15. 8-K Event Results of operations · Regulation FD disclosure
  16. 4 Insider Changes in Ownership
  17. 8-K Event Executive or director change
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 3 Insider Initial Statement of Ownership

Page 33 of 39 · 778 filings